Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-25

Clinical Trial Update: Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) [Phase 2]

View source ↗

Summary

Phase 2 trial update for RAD001 in tuberous sclerosis complex evaluating neurocognition; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RAD001 (everolimus)

Snippet

Sponsor: Mustafa Sahin | Conditions: Tuberous Sclerosis Complex | Phase 2 | Status: COMPLETED | Results posted: 2018-01-25